UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000034869
Receipt No. R000039604
Scientific Title A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of two dose levels of BCX7353 as an oral treatment for the prevention of attacks in subjects with hereditary angioedema
Date of disclosure of the study information 2018/11/13
Last modified on 2019/05/14 18:27:12

No. Disposal Last modified on Item of update
1 Insert 2018/11/12 19:58:12
2 Update 2018/11/13 17:34:08 Classification by specialty
3 Update 2018/11/14 07:35:19 Division
Nationality of Funding Organization
Nationality of Funding Organization
Research ethics review
Institutions
4 Update 2018/12/06 21:16:50 Institutions
5 Update 2019/03/26 17:50:11 Recruitment status
Date of IRB
6 Update 2019/05/14 18:27:12 1st name of lead principal investigator
1st name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Division name
Division name
Organization
Organization
Address
Address
Tel
Email


Contact us.